Syenza News (@SyenzaNews) header
Syenza News (@SyenzaNews) profile picture

Stay ahead with the latest in HEOR, Global Market Access, health policy, innovative tech, and groundbreaking research. Brought to you by @Syenza_Corp

Global
Joined March 2017
Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)Photo by Syenza News (@SyenzaNews)
FDA's complete response letter for ivonescimab: 257 of 275 PFS events (93%) came from patients in China. It also cites a modest PFS gain, no significant OS benefit and benefit-risk, and asks for a new multiregional trial. Why it matters: trial geography now shapes US approval.
1
1
76
Five countries are named for SADC group contracting of medicines: South Africa, Mozambique, Lesotho, Seychelles and Tanzania. The pooled procurement Charter was signed in Durban on 12 Nov. No prices or start date yet. For HTA teams: how does it feed national listing?
1
175
🔍 Can comparative effectiveness research (CER) make drug pricing fairer and more evidence-driven? This article explains how integrating CER into pricing frameworks can align prices with real-world value. Read the full article: news.syenza.com/integration-…
1
20
Are formulary changes finally widening access to GLP‑1 therapies? 💊📈 Recent formulary updates are expanding payer coverage and easing utilization controls for GLP‑1 medications ... Read the full article: news.syenza.com/expanded-glp…
16
New post: Could strategic partnerships be the key to widening access to long‑acting lenacapavir for HIV preven Read more: news.syenza.com/hiv-preventi…
19